Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
A new study led by Krembil Scientist Dr. Jérémie Lefebvre [Editor's Note: Link is no longer available] could help make repetitive transcranial magnetic stimulation (rTMS) and other forms of non-invasive brain stimulation more effective for the treatment of depression and other psychiatric illnesses.
rTMS therapy is most commonly used to treat depression that has not improved with medications or psychotherapy. It involves applying a series of short pulses from a strong electromagnet to a particular area of the brain. The pulses gradually cause long-term changes in brain activity, correcting the abnormal patterns of activity that occur in depression.
Although patients with depression have been benefitting from rTMS therapy for over 15 years, some important questions remain in the field. For example, why is rTMS more likely to influence brain activity when it is administered while the brain is performing a mental task—like performing a simple memory test—than when the brain is at rest?
To gain new insight into the mechanisms of rTMS and answer this question, Dr. Lefebvre is combining mathematics with computational models of the brain.
He applied simulated transcranial alternating current stimulation (tACS), a modified version of rTMS involving fluctuating waves of electrical currents instead of a series of pulses, in different conditions of brain activity: one at rest and the other engaged in a task.
He found that when the brain is at rest, cell activity is highly synchronized and resistant to the effect of tACS. In contrast, when the brain is engaged in a mental task, cell activity is much more asynchronous and more easily influenced by tACS.
"Our findings suggest that a patient's brain is most responsive to tACS and rTMS therapy when it is engaged in a mental task," explains Dr. Lefebvre.
"Implementing these findings in the clinic could make the therapy more effective at restoring healthy brain patterns in patients affected by not only depression, but also other psychiatric disorders."
This work was supported by the Natural Sciences and Engineering Research Council of Canada, the National Institute of Mental Health and the Toronto General & Western Hospital Foundation.